Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology - 1 Nov 2018

Lara-Marquez Maria L, Christiansen Sandra C, Riedl Marc A, Herschbach Jack, Zuraw Bruce L

Abstract excerpt

BACKGROUND: The lack of specific biomarkers makes the diagnosis of hereditary angioedema (HAE) with normal levels of C1-inhibitor (C1INH) protein (HAE-nl-C1INH) and idiopathic non-histaminergic angioedema (INHA) difficult. Confirming or excluding these diagnoses is a significant challenge for clinicians evaluating patients with angioedema. OBJECTIVE: To develop a reliable biomarker that would aid the diagnosis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioedema
Share to Bradykinin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement C1 Inhibitor Protein

Share to Histamine

Share to Kallikreins

Share to Magnetic Resonance Imaging

Share to Sensitivity and Specificity

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 29957871
DOI: 10.1111/cea.13219

Genes

INHA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.PMID 29957871Read ↗

Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.Semantic proximity Read ↗

Bradykinin Measurement by LC-MS/MS in Hereditary Angioedema Subjects Enhanced by Cold ActivationSemantic proximity Read ↗

Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.Semantic proximity Read ↗

New insights into hereditary angio-oedema: Molecular diagnosis and therapy.Semantic proximity Read ↗

Definition and classification of hereditary angioedema.Semantic proximity Read ↗

Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.Semantic proximity Read ↗

Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.Semantic proximity Read ↗

Angioedema without urticaria: novel findings which must be measured in clinical setting.Semantic proximity Read ↗

Hereditary and acquired angioedema.Semantic proximity Read ↗

Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.Semantic proximity Read ↗

Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).Semantic proximity Read ↗

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.